top_banner
Cancer News

Recent General News
FDA Approves Iobenguane I 131 (Azedra) for Rare Neuroendocrine Tumors (August 2, 2018)

The US Food and Drug Administration (FDA) today approved Azedra (iobenguane I 131) for the treatment of pheochromocytoma or paraganglioma, which are rare neuroendocrine tumors of the adrenal gland and... Continue Reading

FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults (May 24, 2018)

Encouraging more widespread innovation and development of safe and effective treatments for opioid use disorder remains top agency priority The U.S. Food and Drug Administration today approved Lucemyra... Continue Reading

FDA Approves Aimovig, A Novel Preventive Treatment for Migraine Headaches (May 21, 2018)

According to Dr. Jessica Ailani, MD, associate professor of neurology at MedStar’s Georgetown University Hospital and director of the MedStar Georgetown Headache Center, migraines affect over 36 million... Continue Reading

What is a Venous Access Device and What Types are Used for Cancer Patients? (May 9, 2018)

A venous access device (VAD) is a surgically implanted device that provides long-term access to a major vein. A VAD can be useful for patients undergoing systemic treatment with precision cancer medicines... Continue Reading

Lutathera Pepetide Receptor Radionuclide Therapy for NETs (May 3, 2018)

CancerConnect News: Lutathera (lutetium Lu 177 dotatate) was recently approved for the treatment of neuroendocrine tumors (NETs) that typically occur in the pancreas and gastrointestinal tract. This is... Continue Reading

CancerConnect – Online Support & Networking for Cancer Patients (March 21, 2018)

Social networking sites are rapidly growing, giving patients with cancer a place to connect with others. On line social groups on Facebook, discussion boards, and peer to peer networking connections have... Continue Reading

Managing a rare cancer (March 1, 2018)

Managing a rare cancer diagnosis presents unique challenges. One survivor shares her tips for navigating the sometimes-murky waters. CancerConnect News: Happy New Year: January 7  (the day I became really... Continue Reading

FDA Approves Lutathera for Treatment for Certain Digestive Tract Cancers (February 6, 2018)

CancerConnect News: The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called... Continue Reading

Cancer Patients are Relatively Unaware of the Role of Precision Cancer Medicine, Genomics and Biomarker Testing (January 8, 2018)

CancerConnect News: Precision cancer medicines and the companion tests used to identify them are increasingly important in the management of cancer.  It is important to understand how aware patients are... Continue Reading

What to Tell Children when Facing a Diagnosis of Cancer (December 14, 2017)

If you have children in your life, you already know that they tend to be creatures of habit who rely on their daily routine. There may be unexpected changes in their routine with your fight against cancer,... Continue Reading

Next Page »